Kexing Biopharm Co., Ltd. (SHA:688136)
China flag China · Delayed Price · Currency is CNY
25.89
-2.75 (-9.60%)
Apr 29, 2026, 3:00 PM CST

Kexing Biopharm Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Cash & Equivalents
650.43554.56568.8785.38877.62
Upgrade
Cash & Short-Term Investments
650.43554.56568.8785.38877.62
Upgrade
Cash Growth
17.29%-2.50%-27.58%-10.51%-20.41%
Upgrade
Accounts Receivable
727.3563.82342.04387.44382.62
Upgrade
Other Receivables
20.1215.94.453.252.84
Upgrade
Receivables
747.43579.72346.49390.69385.46
Upgrade
Inventory
139.22141.81191.36208.18172.16
Upgrade
Other Current Assets
70.2811.7226.9727.0625.57
Upgrade
Total Current Assets
1,6071,2881,1341,4111,461
Upgrade
Property, Plant & Equipment
1,0991,1771,2001,053936.24
Upgrade
Long-Term Investments
311.58203.41245.3215247.46
Upgrade
Other Intangible Assets
229.48225.14158.72165.8226.96
Upgrade
Long-Term Accounts Receivable
---0.31-
Upgrade
Long-Term Deferred Tax Assets
120.71117.22133.9880.8312.1
Upgrade
Long-Term Deferred Charges
97.2350.373.08-21.82
Upgrade
Other Long-Term Assets
68.09101.02156.61438.91123.64
Upgrade
Total Assets
3,5343,1623,0313,1652,829
Upgrade
Accounts Payable
229.1871.9156.0267.7865.73
Upgrade
Accrued Expenses
35.7112.9884.1492.8997.63
Upgrade
Short-Term Debt
162.83269.12120.7162.69276.26
Upgrade
Current Portion of Long-Term Debt
504.41313.25275.0351.78-
Upgrade
Current Portion of Leases
-12.456.719.8718.39
Upgrade
Current Income Taxes Payable
13.26----
Upgrade
Current Unearned Revenue
12.929.7820.4417.997.16
Upgrade
Other Current Liabilities
62.9696.91106.97126.36138.44
Upgrade
Total Current Liabilities
1,021886.4669.99539.37603.61
Upgrade
Long-Term Debt
727.7611.18695.84779.23263.37
Upgrade
Long-Term Leases
1.8214.7817.7924.9643.25
Upgrade
Long-Term Unearned Revenue
11.283.155.320.750.99
Upgrade
Long-Term Deferred Tax Liabilities
18.997.4811.3614.557.12
Upgrade
Total Liabilities
1,7811,5231,4001,359918.34
Upgrade
Common Stock
201.26199.64199.2198.7198.7
Upgrade
Additional Paid-In Capital
1,3131,2881,2821,2741,266
Upgrade
Retained Earnings
316.57176.78145.3335.59445.76
Upgrade
Treasury Stock
-80.36-31.12---
Upgrade
Comprehensive Income & Other
0.931.11-0.01--
Upgrade
Total Common Equity
1,7511,6351,6261,8081,911
Upgrade
Minority Interest
1.514.344.77-2.53-
Upgrade
Shareholders' Equity
1,7531,6391,6311,8061,911
Upgrade
Total Liabilities & Equity
3,5343,1623,0313,1652,829
Upgrade
Total Debt
1,3971,2211,1161,039601.27
Upgrade
Net Cash (Debt)
-746.33-666.22-547.26-253.16276.35
Upgrade
Net Cash Growth
-----64.88%
Upgrade
Net Cash Per Share
-3.79-3.39-2.76-1.261.40
Upgrade
Filing Date Shares Outstanding
191.63197.76199.2198.7198.7
Upgrade
Total Common Shares Outstanding
191.63197.76199.2198.7198.7
Upgrade
Working Capital
586.1401.41463.63871.94857.2
Upgrade
Book Value Per Share
9.148.278.169.109.62
Upgrade
Tangible Book Value
1,5221,4101,4671,6431,884
Upgrade
Tangible Book Value Per Share
7.947.137.378.279.48
Upgrade
Buildings
-754.25662.95609.2361.78
Upgrade
Machinery
-514.22370.42326.3243.82
Upgrade
Construction In Progress
-176.82372.56256.57428.52
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.